These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17583235)

  • 61. Identification of novel mechanisms involved in generating localized vulvodynia pain.
    Falsetta ML; Foster DC; Woeller CF; Pollock SJ; Bonham AD; Haidaris CG; Stodgell CJ; Phipps RP
    Am J Obstet Gynecol; 2015 Jul; 213(1):38.e1-38.e12. PubMed ID: 25683963
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Localized Provoked Vulvodynia-An Ignored Vulvar Pain Syndrome.
    Paavonen J; Eschenbach DA
    Front Cell Infect Microbiol; 2021; 11():678961. PubMed ID: 34222047
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vulvodynia as a possible somatization disorder. More than just an opinion.
    Mascherpa F; Bogliatto F; Lynch PJ; Micheletti L; Benedetto C
    J Reprod Med; 2007 Feb; 52(2):107-10. PubMed ID: 17393771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.
    Birol A; Kisa U; Kurtipek GS; Kara F; Kocak M; Erkek E; Caglayan O
    Int J Dermatol; 2006 Aug; 45(8):992-3. PubMed ID: 16911396
    [No Abstract]   [Full Text] [Related]  

  • 65. Local and Systemic Inflammation in Localized, Provoked Vestibulodynia: A Systematic Review.
    Chalmers KJ; Madden VJ; Hutchinson MR; Moseley GL
    Obstet Gynecol; 2016 Aug; 128(2):337-47. PubMed ID: 27400010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperoxaluria in women with vulvar vestibulitis syndrome.
    Greenstein A; Militscher I; Chen J; Matzkin H; Lessing JB; Abramov L
    J Reprod Med; 2006 Jun; 51(6):500-2. PubMed ID: 16846091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen receptor expression in vulvar vestibulitis syndrome.
    Eva LJ; MacLean AB; Reid WM; Rolfe KJ; Perrett CW
    Am J Obstet Gynecol; 2003 Aug; 189(2):458-61. PubMed ID: 14520218
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exploring Localized Provoked Vulvodynia: Insights from Animal Model Research.
    Nakhleh-Francis Y; Awad-Igbaria Y; Sakas R; Bang S; Abu-Ata S; Palzur E; Lowenstein L; Bornstein J
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of Estrogen-Related Receptors in Localized Provoked Vulvodynia.
    Aalto A; Huotari-Orava R; Luhtala S; Mäenpää J; Staff S
    Biores Open Access; 2020; 9(1):13-21. PubMed ID: 32117596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of magnetic resonance imaging in vulvodynia.
    Lewis FM; Harrington CI
    J Reprod Med; 1997 Mar; 42(3):169. PubMed ID: 9109086
    [No Abstract]   [Full Text] [Related]  

  • 71. Elevated tissue levels of tumor necrosis factor-α in vulvar vestibulitis syndrome.
    Seckin-Alac E; Akhant SE; Bastu E; Tuzlalik S; Yavuz E
    Clin Exp Obstet Gynecol; 2014; 41(6):691-3. PubMed ID: 25551965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Self-compassion, perfectionism, impostor phenomenon, stress and anxiety in patients with localized provoked vulvodynia.
    Andersson N; Abdiweli H; Boman J; Nylander E
    J Psychosom Obstet Gynaecol; 2023 Dec; 44(1):2229008. PubMed ID: 37402237
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inflammation, lipids, and pain in vulvar disease.
    Falsetta ML; Maddipati KR; Honn KV
    Pharmacol Ther; 2023 Aug; 248():108467. PubMed ID: 37285943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.
    Falsetta ML; Foster DC; Bonham AD; Phipps RP
    BJOG; 2017 Jan; 124(2):210-218. PubMed ID: 27312009
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets.
    Zanotta N; Campisciano G; Scrimin F; Ura B; Marcuzzi A; Vincenti E; Crovella S; Comar M
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():66-70. PubMed ID: 29852336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent advances in understanding provoked vestibulodynia.
    Lev-Sagie A; Witkin SS
    F1000Res; 2016; 5():2581. PubMed ID: 27853523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytokine profiles and their roles in development of provoked vulvodynia.
    Le D; Le T; Sanchez A; Gandhi K; Garza J; Gibson A; Galloway M; Ventolini G
    J Reprod Immunol; 2024 Sep; 165():104313. PubMed ID: 39106543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunological and genetic characterization of women with vulvodynia.
    Gerber S; Witkin SS; Stucki D
    J Med Life; 2008; 1(4):432-8. PubMed ID: 20108524
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia.
    Haefner HK
    J Low Genit Tract Dis; 2007 Jan; 11(1):48-9. PubMed ID: 17194952
    [No Abstract]   [Full Text] [Related]  

  • 80. Vulvodynia and fungal association: a preliminary report.
    Ventolini G; Gygax SE; Adelson ME; Cool DR
    Med Hypotheses; 2013 Aug; 81(2):228-30. PubMed ID: 23707510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.